John Patrick Jr Shannon

CIK 1553595 · See Remarks · last filed 2026-02-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.68M

Companies

2

Total Filings

28

Lifetime Open-Market Net

$104.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XERS See Remarks 3,046,328 $6.79 $20.68M $63.5K 24 2026-02-02
Durata Therapeutics, Inc. (DRTX) Delisted Chief Commercial Officer 0 $41.2K 3 2014-11-18

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-02-18 XERS Buy (P) +12,048 $50.0K EDGAR
2020-01-06 XERS Grant (A) +438 $2.6K EDGAR
2019-07-03 XERS Grant (A) +1,138 $11.1K EDGAR
2019-02-01 XERS Grant (A) $0 EDGAR
2018-06-27 XERS Conv (C) +8,983 $0 EDGAR
2014-11-18 Durata Therapeutics, Inc. (DRTX) Delisted Disp (D) −11,000 $0 EDGAR
2014-08-13 Durata Therapeutics, Inc. (DRTX) Delisted Buy (P) +3,000 $41.2K EDGAR
2013-02-14 Durata Therapeutics, Inc. (DRTX) Delisted Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.